nach oben

Reactions Weekly

Erschienen in:

01.09.2014 | Case report

Methylnaltrexone bromide

Nausea, flatulence and dizziness in a paediatric patient: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Excerpt

A patient aged between 4−17 years [exact age and sex not stated] developed nausea, flatulence and dizziness after receiving methylnaltrexone bromide. The patient, who had cancer, had opioid-induced constipation. The patient received a single SC injection of methylnaltrexone bromide 3−12 mg [exact dose not stated]. The patient subsequently experienced flatulence, nausea and dizziness [time to reaction onset and outcome not stated]. …

Rodrigues A, et al. Methylnaltrexone for opioid-induced constipation in pediatric oncology patients. Pediatric Blood and Cancer 60: 1667-1670, No. 10, Oct 2013. Available from: URL: http://doi.org/10.1002/pbc.24615 - CanadaPubMedCrossRef

Titel: Methylnaltrexone bromide
Nausea, flatulence and dizziness in a paediatric patient: case report
Publikationsdatum: 01.09.2014
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2014
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-014-3746-5

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Methylnaltrexone bromide

Nausea, flatulence and dizziness in a paediatric patient: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2014

Cetirizine/hydroxyzine

Aspirin

Warfarin overdose

Etoposide

Infliximab

Irbesartan/olmesartan medoxomil